Institute of Biomedicine and Genome-Scale Biology Research Program, University of Helsinki, Finland.
Bioinformatics. 2011 Mar 15;27(6):887-8. doi: 10.1093/bioinformatics/btr019. Epub 2011 Jan 12.
Gene copy number and DNA methylation alterations are key regulators of gene expression in cancer. Accordingly, genes that show simultaneous methylation, copy number and expression alterations are likely to have a key role in tumor progression. We have implemented a novel software package (CNAmet) for integrative analysis of high-throughput copy number, DNA methylation and gene expression data. To demonstrate the utility of CNAmet, we use copy number, DNA methylation and gene expression data from 50 glioblastoma multiforme and 188 ovarian cancer primary tumor samples. Our results reveal a synergistic effect of DNA methylation and copy number alterations on gene expression for several known oncogenes as well as novel candidate oncogenes.
CNAmet R-package and user guide are freely available under GNU General Public License at http://csbi.ltdk.helsinki.fi/CNAmet.
基因拷贝数和 DNA 甲基化的改变是癌症中基因表达的关键调控因素。因此,同时显示甲基化、拷贝数和表达改变的基因很可能在肿瘤进展中起关键作用。我们已经开发了一种新的软件包(CNAmet),用于高通量拷贝数、DNA 甲基化和基因表达数据的综合分析。为了展示 CNAmet 的实用性,我们使用了 50 个胶质母细胞瘤和 188 个卵巢癌原发性肿瘤样本的拷贝数、DNA 甲基化和基因表达数据。我们的结果揭示了几个已知的癌基因以及新的候选癌基因的 DNA 甲基化和拷贝数改变对基因表达的协同作用。
CNAmet R 包和用户指南可根据 GNU 通用公共许可证在 http://csbi.ltdk.helsinki.fi/CNAmet 上免费获取。